(AND) Andlauer Healthcare Gr - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA0342231077

AND: Pharmaceuticals, Biologics, Vaccines, Medical Devices, Cosmetics

Andlauer Healthcare Group Inc. (TO:AND) operates as a leading provider of specialized logistics and transportation solutions tailored to the healthcare industry in Canada and the United States. Founded in 1991 and headquartered in Vaughan, Canada, the company functions as a subsidiary of Andlauer Management Group Inc. Its services are divided into two primary segments: Specialized Transportation and Healthcare Logistics. The company offers a comprehensive suite of supply chain management solutions, including distribution, warehousing, and inventory management, alongside specialized packaging services such as co-packing, assembly, and custom packaging solutions. Additionally, Andlauer provides temperature-controlled storage and transportation, air freight forwarding, and last-mile delivery services, catering to a diverse range of healthcare products, including pharmaceuticals, biologics, medical devices, and consumer health goods. The companys technology-enabled platform ensures seamless integration with clients systems, making it a critical partner for healthcare manufacturers, distributors, and 3PL providers.

Over the next three months, Andlauer Healthcare Group is expected to demonstrate steady performance, supported by its strong market position in the healthcare logistics sector. From a technical standpoint, the stock has shown upward momentum, with the 20-day moving average (SMA 20: 43.72) surpassing the 50-day moving average (SMA 50: 41.67), indicating short-term bullish sentiment. However, the relatively high Average True Range (ATR: 1.53) suggests moderate volatility. On the fundamental side, the companys high price-to-earnings ratio (P/E: 33.72) and forward P/E (30.40) reflect investor confidence in its growth prospects, despite potential valuation concerns. With a robust return on equity (RoE: 14.95%) and a proven track record of operational efficiency, Andlauer is well-positioned to capitalize on increasing demand for specialized healthcare logistics services.

Additional Sources for AND Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AND Stock Overview

Market Cap in USD 1,519m
Sector Industrials
Industry Integrated Freight & Logistics
GiC Sub-Industry Air Freight & Logistics
IPO / Inception

AND Stock Ratings

Growth Rating 41.9
Fundamental 62.9
Dividend Rating 62.1
Rel. Strength 37.4
Analysts -
Fair Price Momentum 52.77 CAD
Fair Price DCF 121.00 CAD

AND Dividends

Dividend Yield 12m 0.94%
Yield on Cost 5y 1.57%
Annual Growth 5y 14.76%
Payout Consistency 98.3%

AND Growth Ratios

Growth Correlation 3m 22.7%
Growth Correlation 12m 59.2%
Growth Correlation 5y 14.6%
CAGR 5y 13.85%
CAGR/Max DD 5y 0.42
Sharpe Ratio 12m 0.15
Alpha 32.18
Beta 0.061
Volatility 29.22%
Current Volume 112.9k
Average Volume 20d 55.1k
What is the price of AND stocks?
As of May 09, 2025, the stock is trading at CAD 53.50 with a total of 112,854 shares traded.
Over the past week, the price has changed by +0.30%, over one month by +35.44%, over three months by +15.98% and over the past year by +33.53%.
Is Andlauer Healthcare Gr a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Andlauer Healthcare Gr (TO:AND) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 62.88 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AND as of May 2025 is 52.77. This means that AND is currently overvalued and has a potential downside of -1.36%.
Is AND a buy, sell or hold?
Andlauer Healthcare Gr has no consensus analysts rating.
What are the forecast for AND stock price target?
According to ValueRays Forecast Model, AND Andlauer Healthcare Gr will be worth about 57 in May 2026. The stock is currently trading at 53.50. This means that the stock has a potential upside of +6.52%.
Issuer Forecast Upside
Wallstreet Target Price 54.8 2.5%
Analysts Target Price - -
ValueRay Target Price 57 6.5%